The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).

På svenska

Author

  • Marcus Lind
  • Irl B Hirsch
  • Jaakko Tuomilehto
  • Sofia Dahlqvist
  • Bo Ahrén
  • Ole Torffvit
  • Stig Attvall
  • Magnus Ekelund
  • Karin Filipsson
  • Bengt-Olov Tengmark
  • Stefan Sjöberg
  • Nils-Gunnar Pehrsson
Show all

Summary, in English

What are the effects of liraglutide, an incretin based treatment, on glycaemic control in people with type 2 diabetes treated with multiple daily insulin injections?

Publishing year

2015

Language

English

Pages

5364-5364

Publication/Series

BMJ: British Medical Journal

Volume

351

Document type

Journal article

Publisher

BMJ Publishing Group

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Diabetes - Molecular Metabolism

ISBN/ISSN/Other

  • ISSN: 1756-1833